| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||||||||
Net loss | ||||||||||||
-38,249 | -36,698 | -39,403 | -44,963 | -42,724 | -38,980 | 0 | 0 | 0 | - | - | - | - |
Net loss | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 |
Adjustments to reconcile net loss to cash used in operating activities: | ||||||||||||
Depreciation and amortization | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Deferred rent | ||||||||||||
- | - | - | - | - | -345 | 0 | 0 | 0 | - | - | - | - |
Depreciation | ||||||||||||
- | - | - | - | - | - | 682 | 612 | 519 | 419 | 0 | 0 | 0 |
Deferred rent | ||||||||||||
- | - | - | - | - | - | - | - | - | 109 | 0 | 0 | 0 |
Stock-based compensation | ||||||||||||
7,927 | 6,520 | 6,535 | 7,825 | 7,783 | 7,173 | 5,937 | 3,958 | 3,390 | 2,775 | 0 | 0 | 0 |
Operating lease right of use amortization | ||||||||||||
4,351 | 4,354 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Non-cash investment expense (income) | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Other non cash charges | ||||||||||||
- | - | - | 0 | 0 | - | - | - | - | - | - | - | - |
Changes in operating assets and liabilities: | ||||||||||||
Account receivable | ||||||||||||
0 | - | - | - | - | - | - | - | - | - | - | - | - |
Research and development contract advances | ||||||||||||
- | - | - | - | - | - | - | - | 0 | - | - | - | 0 |
Prepaid expenses and other current assets | ||||||||||||
281 | -487 | 254 | -1,036 | 445 | 701 | 917 | 2,809 | 1,577 | 1,116 | 0 | 0 | 0 |
Operating lease liability | ||||||||||||
-4,608 | -4,277 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Deposits | ||||||||||||
- | - | - | - | - | - | - | -508 | -1,017 | -58 | 0 | 0 | 0 |
Accounts payable | ||||||||||||
-1,293 | -1,152 | 181 | 1,745 | 1,625 | 376 | 0 | 0 | 0 | - | - | - | - |
Accrued expenses | ||||||||||||
-1,004 | 439 | -713 | 1,455 | 1,596 | 636 | 0 | 0 | 0 | - | - | - | - |
Research and development contract liability | ||||||||||||
1,003 | 928 | 6,720 | 6,646 | 4,788 | 4,686 | 0 | 0 | 0 | - | - | - | - |
Net cash used in operating activities | ||||||||||||
-33,265 | -30,796 | -28,256 | -25,346 | -25,126 | -26,410 | 0 | 0 | 0 | - | - | - | - |
Cash flows from investing activities | ||||||||||||
Accounts payable and accrued expenses | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 |
Accrued compensation and related expenses | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 |
Net cash used in operating activities | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 |
Purchases of property and equipment | ||||||||||||
- | 46 | 156 | 440 | 1,200 | 1,854 | 1,752 | 1,659 | 1,146 | 1,029 | 0 | 0 | 0 |
Redemption of short term investments | ||||||||||||
- | - | - | 0 | 0 | - | - | - | - | - | - | - | - |
Purchases of marketable securities | ||||||||||||
0 | - | - | - | - | - | - | - | - | - | - | - | - |
Net cash (used in) provided by investing activities | ||||||||||||
-15,984 | 3,446 | 23,278 | -4,313 | -10,200 | -20,354 | 0 | 0 | 0 | - | - | - | - |
Cash flows from financing activities | ||||||||||||
Proceeds from exercise of stock options | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Net cash provided by financing activities | ||||||||||||
50,568 | 50,789 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Net increase/(decrease) in cash, cash equivalents, and restricted cash | ||||||||||||
1,318 | 23,439 | 15,487 | -21,474 | -30,888 | -42,583 | 0 | 0 | 0 | - | - | - | - |
Supplemental disclosures of non-cash investing activities: | ||||||||||||
Net cash used in investing activities | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 |
Net increase (decrease) in cash | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 |
Purchases of property and equipment in accounts payable or accrued expenses | ||||||||||||
0 | - | - | - | - | - | - | - | 0 | - | - | - | 0 |
Accrual of deferred offering costs | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |